Valuation: Coloplast

Market Cap 96.75B 14.93B 12.94B 12.12B 11.06B 20.79B 1,424B 21.11B 143B 55.74B 713B 56.07B 54.85B 2,378B P/E 2026 *
30.7x
P/E 2027 * 16.4x
Enterprise Value 117B 18.12B 15.7B 14.71B 13.42B 25.22B 1,728B 25.61B 173B 67.62B 865B 68.03B 66.55B 2,885B EV / Sales 2026 *
4.08x
EV / Sales 2027 * 3.79x
Free-Float
63.42%
Yield 2026 *
4.74%
Yield 2027 * 5.11%
Manager TitleAgeSince
Chief Executive Officer 55 2026-04-30
Director of Finance/CFO 54 2005-12-31
Chief Operating Officer 59 2008-09-04
Director TitleAgeSince
Director/Board Member 78 2006-12-12
Director/Board Member 56 2009-09-17
Chairman 57 2025-05-04
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 15.31B
-2.43%-0.51%-28.83%-47.61% 15.31B
-2.15%+5.71%+36.84%+129.78% 4.91B
+2.25%-3.23%+267.78%+190.96% 3.21B
+0.07%-1.77%-27.53%-29.75% 2.53B
+0.15%-0.44%-51.43%-59.77% 1.95B
-0.24%-11.68%-31.16%-29.00% 1.88B
+0.76%-0.75%+9.02%-20.83% 1.29B
+0.10%+9.53%+4.83%-12.14% 1.06B
-1.74%-2.55%-8.39%+12.20% 985M
Average -0.24%+0.28%+19.01%+14.87% 3.68B
Weighted average by Cap. -0.59%+0.45%+11.45%+7.46%

Financials

2026 *2027 *
Net sales 28.79B 4.44B 3.85B 3.61B 3.29B 6.19B 424B 6.28B 42.43B 16.59B 212B 16.69B 16.32B 708B 30.76B 4.75B 4.11B 3.85B 3.52B 6.61B 453B 6.71B 45.34B 17.72B 227B 17.83B 17.44B 756B
Net income 3.17B 489M 424M 397M 362M 680M 46.63B 691M 4.67B 1.82B 23.35B 1.84B 1.8B 77.85B 5.91B 912M 790M 740M 675M 1.27B 87B 1.29B 8.71B 3.4B 43.56B 3.42B 3.35B 145B
Net Debt 20.63B 3.18B 2.76B 2.58B 2.36B 4.43B 304B 4.5B 30.4B 11.88B 152B 11.96B 11.7B 507B 19.71B 3.04B 2.64B 2.47B 2.25B 4.23B 290B 4.3B 29.04B 11.35B 145B 11.42B 11.17B 484B
Logo Coloplast
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - ostomy care products (35.5%): bags and equipment used following intestinal operations; - hygiene products (32.2%): urine bags, plugs, urinary testing systems and sets, etc.; - wound care and skincare products (14.1%): wound dressings, bandages, creams and gels; - interventional urology products (10%); - voice and respiratory care products (8.2%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.5%), the United States (23.5%), the United Kingdom (14%), France (10.1%), Germany (9.7%) and other (41.2%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA